Open Access
24 September 2021 Optical coherence tomography of small intestine allograft biopsies using a handheld surgical probe
Evan T. Jelly, Jean Kwun, Robin Schmitz, Alton B. Farris, Zachary A. Steelman, Debra L. Sudan, Stuart J. Knechtle, Adam P. Wax
Author Affiliations +
Funded by: National Science Foundation (NSF), HHS|NIH|National Cancer Institute (NCI)
Abstract

Significance: The current gold standard for monitoring small intestinal transplant (IT) rejection is endoscopic visual assessment and biopsy of suspicious lesions; however, these lesions are only superficially visualized by endoscopy. Invasive biopsies provide a coarse sampling of tissue health without depicting the true presence and extent of any pathology. Optical coherence tomography (OCT) presents a potential alternative approach with significant advantages over traditional white-light endoscopy.

Aim: The aim of our investigation was to evaluate OCT performance in distinguishing clinically relevant morphological features associated with IT graft failure.

Approach: OCT was applied to evaluate the small bowel tissues of two rhesus macaques that had undergone IT of the ileum. The traditional assessment from routine histological observation was compared with OCT captured using a handheld surgical probe during the days post-transplant and subsequently was compared with histophaology.

Results: The reported OCT system was capable of identifying major biological landmarks in healthy intestinal tissue. Following IT, one nonhuman primate (NHP) model suffered a severe graft ischemia, and the second NHP graft failed due to acute cellular rejection. OCT images show visual evidence of correspondence with histological signs of IT rejection.

Conclusions: Results suggest that OCT imaging has significant potential to reveal morphological changes associated with IT rejection and to improve patient outcomes overall.

1.

Introduction

Intestinal transplant (IT) is a life-saving therapy for patients who are unable to absorb adequate nutrients, due to either disease or injury. The small intestine is commonly deemed one of the most challenging organs to be transplanted because of its enhanced immune response.1 Even with many advancements in the field, IT grafts are hypersensitive to reperfusion injury and more vulnerable to rejection, with the 10-year graft and patient survival rates still under 50% and 75%, respectively.2 Unlike other solid organ transplant models, there are no universally accepted biochemical markers with which to diagnose, monitor, or even predict IT graft failure.3 The current gold standard for post-IT evaluation involves constant and coordinated clinical, laboratory, and histopathologic testing. However, there is considerable variability over the approach and frequency of routine biopsy of acute cellular rejection (ACR) across approved IT programs in the United States.4 Excessive excisional biopsy of IT grafts presents several challenges, including increased financial burdens and risk of hemorrhage, perforations, and infection.5

OCT has shown potential utility for assessing the health of transplanted tissues at other organ sites. For example, OCT has successfully evaluated the viability of donor kidney transplants using an automated prediction algorithm.6 development of OCT devices specific to the small intestine has been slow, mainly due to the difficulty of performing enteroscopy across the long intraluminal distance of the small intestine, where surgical intervention and laparoscopy are commonly recommended. Post-IT, an ileostomy is performed; the small bowel is diverted through a minimal incision in the abdomen and maintained over several months to facilitate graft monitoring. This procedure reduces the distance required to be bridged by an optical probe from meters to centimeters to access the majority of the small intestine, enabling observation of the bowel endoscopically to monitor graft rejection.

OCT has become a standard of care for ophthalmic imaging and diagnostics,7,8 although further adoption in other tissues has been slow. While widespread use of OCT is limited in some thick tissues due to its 1  mm penetration depth, OCT is capable of providing micron-scale tomograms, which have proven valuable in experimental settings for imaging of coronary artery disease,911 respiratory lesions,12,13 breast,14 urinary,15 and reproductive16,17systems, among other applications. While some limitations persist, improvements in field of view (FOV),18 automated image analysis,19 image stabilization,20 and cost21 suggest that OCT will emerge as a useful technology across tissue types. Unfortunately, the penetration depth in OCT is governed by the physics of light scattering, and technical advances in penetration in highly scattering tissues are often marginal.22 This represents a significant burden on OCT as a medical device, whereas other tomographic imaging systems such as MRI and PET are not limited by the loss of contrast due to scattered photons. We believe that future OCT technology will rely on robust and straightforward delivery systems that directly relay the probe beam to the tissue of interest to circumvent this fundamental constraint. This avoids the problem of scattering while providing a highly targeted and precise general-purpose imaging modality to clinicians. Unfortunately, such systems have been limited, often relying on highly complex and expensive geometries involving fabricated fiber probes.23,24 Most OCT probes use single-mode optical fibers (SMF) to deliver the OCT signal internally, relying on a mechanical means to spin the sample arm’s distal optics to generate circumferential cross-sectional images.2529 These devices are often complex and expensive, are not built as general-purpose probes, and are still nascent as medical devices.

For OCT probes, the gastrointestinal (GI) tract is a particular area of focus, where previous efforts have made significant progress evaluating or diagnosing conditions, such as Barrett’s esophagus,30 esophageal cancer,31 inflammatory bowel disease,32 and ulcerative colitis.33 However, comparatively few OCT studies have been reported in the small intestine. Partly due to its elongated and sinuous structure and the significant intraluminal distance from either the oral or anal orifices, the small intestine remains difficult to image even with established endoscopic modalities.

Previous OCT of the small intestine often originated as extensions of studies of the stomach, where long GI endoscopes were capable of accessing the pylorus, which marks the region between the stomach and the duodenum.17 Hsiung et al. were among the first to image the small intestine using OCT, imaging excised surgical samples and comparing them against corresponding histology.34 In vivo imaging of the terminal ends of the small intestine has since been realized35,36 and shows that OCT can observe structures such as villi and submucosa.37,38 The clinical relevance of this information can be seen in studies in which OCT has been directly used to diagnose celiac disease in children, reporting sensitivity and specificity of 82% and 100% against histology, respectively, between healthy and atrophic villous structures.39 These results illustrate the diagnostic potential for OCT in the small intestine.

We have previously reported the endoscopic delivery of OCT using a handheld rigid borescope40 and a custom, portable spectral domain OCT (SD-OCT) system shown to offer comparable imaging performance to commercially available systems.41,42 The potential utility of this device was first validated as a method to measure the thickness of knee cartilage for cases of severe osteoarthritis. We now demonstrate the use of this borescope-based OCT system to monitor transplanted small intestinal tissue in a nonhuman primate (NHP) model.

The handheld borescope-based OCT instrument was validated in studies of two rhesus macaques that underwent IT. Progression of transplant allograft rejection was assessed using surveillance surgical biopsies with the results from OCT analysis compared with H&E-stained slides from coregistered biopsies. Our results suggest the potential for OCT to identify morphological features indicative of graft rejection in the small bowel and contribute to the development of transplant monitoring strategies that can facilitate long-term intestinal graft function.

2.

Methods

2.1.

Endoscopic OCT Instrumentation

A compact, portable spectral-domain OCT (SD-OCT) engine, first reported by Kim et al.,41 was used for these studies. The system features a high-powered broadband superluminescent diode (Exalos) with an 840-nm center wavelength and 48-nm full-width at half-maximum (FWHM) bandwidth. To mitigate unwanted intensity fluctuations caused from using an uncooled source, constant background acquisition and subtraction were applied in processing. A custom spectrometer with high spectral resolution (<0.1  nm) that utilized a tall-pixel CMOS line array to reduced sensitivity to temperature fluctuations and mechanical stress was used. Combining these elements yielded a theoretical 2.8-mm imaging depth in air and coherence-limited axial resolution of 7  μm. An onboard small-form-factor (SFF) computer (Intel) coordinated frame acquisition and beam scanning in the OCT probe, rendering (512×512  pixels) B-scans at a rate of 12 frames per second.

We have previously adapted this OCT engine for endoscopic use by adapting a commercial 30 cm rigid borescope with a 4 mm diameter.40 In this study, a prototype 30-deg-angled rigid borescope (Foreal Spectrum) treated with an antireflective coating near 840 nm was employed. The distal profile of the borescope was 4 mm in diameter with a 20-cm long probe. Figure 1 shows the instrument schematic. The fiber optic output from the OCT engine enclosure was collimated using a 10-mm liquid lens (Optotune) and incident on a 3.6-mm wide microelectromechanical system (MEMS) mirror (Mirrorcle). A 4f lens relay produced a scan pattern at the input image plane of the borescope that was then relayed, via a series of internal small relay lenses, to the sample plane at the distal end of the probe. The liquid lens allowed for electronic control of the beam focus for a variable working distance of 0 to 2 mm. The resulting design produced a scanning field of ±0.6  mm about the center axis of the borescope’s back aperture, which yielded a distal scan area of 2.5  mm×2.5  mm after the borescope. Custom software, written in C#, displayed real-time B-scans and allowed for user adjustments to the focal plane, numerical dispersion correction,43 and sample scan pattern.

Fig. 1

Schematic illustration of Borescope OCT system. Custom GUI software control an SD-OCT engine: 840±20  nm broadband light source, custom-built spectrometer, and SFF PC. The instrument’s sample scanning mechanisms coupled NIR light, delivered by SMF, to a handheld 30-deg-angled rigid borescope.

JBO_26_9_096008_f001.png

2.2.

OCT Borescope

The first iteration of a borescope OCT device featured a 30-cm long flat-angled borescope.40 However, many endoscopic applications require a low-angle direction of view (DOV) to adequately compensate for unique approach angles between the surgical entry port and operative site. For this study, a 30-deg DOV borescope was used to realize our design’s clinical potential further. Scanning of the OCT beam was limited to one lateral dimension to avoid nonsymmetric group-velocity dispersion introduced from a nonuniform pathlength across the acute axis of the borescope’s 30-deg wedge prism. A 24.46% loss of power was observed between the scanner body and the borescope output due to the high number of air-spaced relay lenses within the borescope. In this study, the length of the borescope used was 10 cm less than in our previous work, delivering 2.12 mW at the sample and 92-dB signal-to-noise (SNR) and improving overall transmissivity and sensitivity by 8% and 5.7%, respectively. Axial resolution was measured at 8.2  μm, using the FWHM of the A-line peak of a mirror located at the borescope’s focal plane and within <1% of the theoretical axial resolution of 8.13  μm. The lateral spot size of the system was 10.3  μm FWHM across the 2.5  mm×2.5  mm FOV, as measured using a CMOS camera (Flea3, FLIR, 4.8  μm pixels). For the minimum observed spot size of 10.3  μm, power at the sample remained below the maximum permissible exposure for skin established by the American National Standards Institute (ANSI Z136.1).

2.3.

Animal IT Model

Animal subjects ranging from 4 to 6 kg were purchased from Alpha Genesis (Yemassee, South Carolina). Two male rhesus macaques, hereinafter referred to as subjects 1 and 2, underwent orthotopic IT with the Abdominal Transplant Group at Duke University. Donor–recipient pairs were maximally major histocompatibility complex classes I and II mismatched. Animal subjects did not receive any immunosuppressive treatments to study unmanipulated rejection in allogeneic IT. Intestinal biopsies were performed on days 0, 2, and 6 after transplant from a defunctionalized limb of proximal jejunum via partial laparotomy. In addition, optical coherence tomography (OCT) of each biopsy was utilized for minimally invasive surveillance of the graft. The study endpoint was defined as clinical evidence of acute rejection with intestinal graft failure. All animals were housed in accordance with the National Institutes of Health (NIH) guidelines and were approved by the Duke Institutional Animal Care and Use Committee (IACUC number: 087-19-04).

2.4.

NHP OCT Imaging Protocol

OCT imaging for this study was performed coinciding with surgical observation of NHP with IT grafts. Imaging technicians in surgical protective attire were presented with ex vivo IT allograft surgical specimens immediately following removal. The working distance of the scanning probe was set to 1  mm to provide contactless imaging of the biopsy. Handheld operation of the scanning probe allowed for unrestricted movement of the probe and rapid adjustments and translation between regions of interest. Operators securely held the base of the scanner body while placing a second hand near the distal-end of the probe to increase stability to allow for finer manipulation of the imaging field. OCT B-scans were acquired across the entire volume of the biopsy. B-scans were captured at a rate of 12 fps and compiled into 10-frame averages in postprocessing. After OCT imaging, IT graft samples were preserved for later histological analysis.

2.5.

Histology

Intestinal graft tissue biopsies were fixed with 10% neutral buffered formalin and submitted for processing into paraffin blocks. Paraffin blocks underwent serial sectioning (5  μm) and staining with hematoxylin and eosin (H&E) for histological evaluation and rejection grading. Whole slides of graft samples were scanned with an Aperio ScanScope XT (Aperio Technologies, Inc., Vista, California). Allograft histology was evaluated in a blinded fashion by a trained transplant pathologist (A.B.F).

3.

Results

3.1.

Comparison of Jejunum and Ileum

Ex vivo jejunum and ileum samples were imaged with the 30-cm flat-angled handheld OCT probe immediately after tissue harvest. Representative OCT images of the healthy NHP jejunum and ileum are shown in Figs. 2(a) and 2(b), respectively. The general structures of the jejunum and ileum of the rhesus macaque are comparable, as the intestine’s mucosal lining is fairly uniform throughout its entire length.44 Images of both the jejunum and ileum clearly display the characteristic striping features of intestinal villi. The epithelial cell layer is also visible, appearing as a thin scattering band separating an outer layer of mucus from individual villi.

Fig. 2

Optical coherence tomography of the small intestine performed using a handheld surgical probe. (a) Ex vivo OCT B-scans of an NHP jejunum biopsy. (b) Ex vivo OCT B-scans of an NHP ilium biopsy. Examples of intestinal crypts and villus structures are identified by red and orange arrows, respectively. Blue 1 arrows indicate mirror artifacts resulting from internal lenses of borescope. 10-frame average; scale bars=250  μm.

JBO_26_9_096008_f002.png

Morphological differences were noted across image sets from the jejunum and ileum upon inspection. The shape of villi can vary in form-factor across the length of the small intestine, ranging from narrow finger-like structures to broader leaf-like forms.45 The mean and standard deviation of villi thickness across both samples were measured manually from five randomly selected B-scans for each sample using ImageJ. Thicknesses varied substantially in 26 total measurements for each sample. In general, the jejunum exhibited thicker villi (146±60  μm), whereas the ileum exhibited thinner villi (108±22  μm). This result is expected as a higher density of villi is observed near the ileum terminus.45 Further, a paired t test comparing matched OCT-derived villi thicknesses with measurements made from corresponding H&E images returned a p value of 0.63, indicating no significant difference in the means observed between the two techniques.

3.2.

Identification of Intestinal Landmarks

Figure 3 shows 10-frame averaged OCT B-scans captured using the handheld 30-deg angled DOV borescope OCT device against H&E micrographs from the corresponding sample. Images were acquired from normal tissue samples harvested prior to transplant from an NHP-IT surgical study. The 5.7% improvement in SNR in OCT images from previous designs is visually apparent when compared with images in Fig. 2. The borescope provides good contrast by reducing unwanted background intensity due to a reduction in optical elements in the borescope’s relay arm; this feature reduces the effect from optical surface reflections and internal etaloning overall. OCT images captured in this configuration also show no signs of nonuniform field distortion resulting from scanning along the borescope’s angled prism.

Fig. 3

Representative cross-sectional imaging of ex vivo NHP ileum using OCT and histology. (a) An interior projection OCT B-scan (left) and corresponding histology (right) identifying a villus (V) and crypts (C) of healthy intestinal mucosa. (b), (c) Two exterior projection OCT B-scans (left) and corresponding histology (right) identifying several structural layers: circular smooth muscle (CM), myenteric plexus (MP), longitudinal 1 smooth muscle (LM), serous membrane (S), submucosa (SM), and mucosa (M). OCT images are 10-frame averages. Scale bars=250  μm.

JBO_26_9_096008_f003.png

Throughout the length of the small intestine, the epithelial layer is identified by two major morphological features: villi and crypt epithelium. As previously discussed, villi are presented as long narrow projections that protrude into the intestinal lumen; crypts, or intestinal glands, are moat-like invaginations of the lower 20% of the epithelium and are the site of epithelial cell division.46 Two interior projection OCT B-scans are presented with comparative H&E images in Fig. 3(a). We identified healthy mucosal structures on the OCT images, including a clear demarcation between the outer mucus and lamina propria separated by the higher-scattering epithelial cell layer of healthy villus. Further, OCT depth penetration was sufficient for visualizing the beginning of the crypt region of the sample.

Several layers of specialized tissue make up the GI wall surrounding the lumen of the small intestine: serous membrane, muscularis propria, submucosa, and mucosa. These layers are identified in Figs. 3(b) and 3(c). The muscularis propria consists of two primary types of smooth muscle, longitudinal and circular, working in tandem to mediate peristalsis. OCT images acquired from the exterior of the small intestine exhibit distinct layers resembling the same morphology as the boundaries between the inner and outer muscular layers seen in corresponding H&E [Fig. 3(b)]. Further, the myenteric plexus (Auerbach’s plexus), identified by a dense clustering of ganglion cells, can be observed between these two muscle types. Several features can be seen in the OCT images of the muscularis propria, which correlate well with these features. Layers of the muscularis propria range in size distribution across images. In Fig. 4(b), the outer muscular layer thickness is reduced, yielding improved contrast of shallower layers. The serous membrane, the outermost layer of small intestine consisting of several thin layers of mesothelium, is observed in both representative images from OCT imaging and histology. The connective tissue framework of the submucosa, as well as the beginning of the mucosal layer, can also be clearly identified in both sets.

Fig. 4

OCT B-scans (left) and corresponding histology (right) images of NHP ileum IT allograft ischemia. (a) External and (b) internal projections of excised samples of normal IT allografts observed at day of transplantation. (c) External and (d) internal projection of excised samples of highly rejected IT allografts observed one day after IT. OCT images are 10-frame averages; scale bars=250  μm.

JBO_26_9_096008_f004.png

3.3.

Evaluation of IT Graft Ischemia (Subject 1)

Observations of ITs in this study were guided by the dynamics of transplant failure in our NHP model. Immediately following transplantation, subject 1 suffered a thrombosis of the artery, leading to graft ischemia prior to the scheduled imaging on the day following transplantation. Surgical samples of the failed IT allograft were removed immediately following sacrifice on day 1 and presented to OCT imaging technicians within a half hour of tissue harvest. Example OCT images from subject 1 allograft captured both on the initial day of transplantation and prior to expiry are presented in Fig. 4. OCT images of healthy allograft samples from subject 1 [Figs. 4(a) and 4(b)] maintain a high degree of contrast between all previously identified layers of both the exterior GI wall and lumen, showing no indication of pathology. OCT images from ischemic IT tissue 24 h post-transplant [Figs. 4(b) and 4(c)] present stark comparison with healthy tissue. Figure 4(c) shows a blurring of internal structures and a strong reduction in optical scattering of the exterior GI wall. These are strong indications of changes in the intracellular morphology and consistent with reports of apoptotic tissue damage imaged using OCT.47 Images of the same sample from an internal projection of the lumen [Fig. 4(d)] reveal a frequency of sponge-like structures observed throughout the rejected tissue samples, resembling severely edematous tissue imaged using OCT.48

3.4.

Evaluation of IT Graft Rejection (Subject 2)

For subject 2, the small bowel rejection occurred gradually, allowing for evaluation of tissue pathology over the full 7-day trial. Analysis of fixed and sectioned biopsy samples under H&E staining by IT pathology experts at Emory University was utilized to visualize the tissue alterations and gave guidance for identifying structures using OCT. At day 0, the intestinal mucosa showed no diagnostic abnormality. At day 2 after transplantation, the graft intestinal mucosa showed slight villous blunting, increased intraepithelial lymphocytes, and an occasional neutrophilic crypt abscess. Relatively sparse apoptotic bodies were present. Overall, the findings were compatible with mild to moderate (grades 1 to 2) ACR, and the neutrophilic crypt abscess could represent the residual effects of reperfusion injury. At day 6 after transplantation, the graft intestinal mucosa showed marked injury with a total loss of glandular bodies or “crypt dropout,” epithelial sloughing, lamina propria hemorrhage, and foci of frank ulceration. In areas of preserved epithelium, scattered apoptotic bodies could also be seen, and there was a patchy increase in intraepithelial lymphocytes. Graft findings overall were compatible with severe (grade 3) ACR.49 The key biomarkers of ACR identified by histological analysis are presented in Fig. 5.

Fig. 5

Cellular biomarkers of ACR in IT grafts. H&E-stained NHP allograft specimens of the small intestine on days 0, 2, and 6 after transplantation. Insets: 85×85  μm FOV with corresponding location marked by a dashed line. Scale bars=250  μm.

JBO_26_9_096008_f005.png

Apparent changes in tissue composition were observed upon review of OCT images from subject 2 IT specimens. Example OCT images from subject 2 allografts, presented as Fig. 6, illustrate several biomarkers of transplant rejection. At day 0, the initial day of the transplant, there was strong evidence of healthy mucosal structures in the OCT images [Fig. 6(a)]. Large features with greatly reduced scattering are present at day 2 (grades 1 to 2 ACR). These features are likely indicative of lamina propria inflammation and diffuse epithelial reactive changes in crypts identified by H&E. This crypt dropout can be confirmed by OCT. A decrease in overall scattering may be the result of abundant and focally confluent crypt apoptotic bodies [Fig. 6(b)]. At day 6 (grade 3 ACR), OCT images exhibit signs of full rejection. Prominent ulcerations of the muscularis propria were identified by OCT. Further, the structure of rejected tissue is dominated by sponge-like infarcts as well as significant changes in the scattering properties of the sample. This morphology is mirrored in frequency by inflammation within corresponding H&E micrographs indicated by neutrophilic infiltration and increased intraepithelial lymphocytes throughout the sample [Fig. 6(c)].

Fig. 6

Progression of ACR in IT grafts from an NHP model. OCT B-scans (left) and corresponding histology (right) of surgically excised IT allografts imaged 0, 2, and 6 days post IT visualizing (a) negative, (b) mild to moderate, and (c) severe grades of ACR. 10-frame average OCT images; scale bars=250  μm.

JBO_26_9_096008_f006.png

4.

Discussion

OCT is presented as a modality for evaluating the status of transplanted intestinal tissue. The utility of a handheld rigid endoscopic probe demonstrates the potential to fit into the clinical workflow for graft monitoring. The rigid borescope enables access to transplanted tissue in patients using a temporary ostomy during the critical early weeks post-transplantation. The use of the 30-deg DOV borescope applied here further advances the technology by better adapting it for clinical imaging, while also improving throughput and SNR. Future work may involve combined OCT and traditional endoscopic visual or fluorescence imaging through the addition of a white-light light source and camera fitted to the borescope’s auxiliary port. The combination will allow for coregistration of the white-light images with OCT-imaged tissue sites. Continued studies will also look to provide analysis of histological structure with quantitative analysis of in vivo OCT images. Given the expected range of tissue status, these data will be very useful for developing biomarkers in the NHP-IT model.

ACR is the leading cause of post-operative IT graft loss, with most patients experiencing at least one episode.50 There are many indications of ACR in IT patients; however, there are no universally accepted markers to predict rejection. Numerous chemical biomarkers have been investigated to predict and even exclude rejection, including citrulline levels and cytokine profiles in the peripheral blood, stool calprotectin levels, and changes in various transcriptome sets.5153 However, none have shown the required sensitivity, reproducibility, or turnaround speeds required to be universally recommended for post-transplant evaluation.54 Across all published grading schemes, apoptotic body count (ABC) in crypt cells is identified as a primary indicator of onset ACR. Changes in epithelial morphology, density, and composition, which occur due to apoptosis in crypt bodies, will alter optical scattering properties, which can be visualized using OCT.

Epithelial injury and inflammation in the lamina propria are important correlates for identifying allograft rejection.55 In many low ABC cases, increased mononuclear inflammation and crypt injury within the allograft are predictive of graft rejection.56 However, increased inflammation in the lamina propria is most easily diagnosed using endoscopic data and may not be easily observable by H&E during the initial months post-transplantation when early detection is critical. OCT images of intermediate stage ACR were dominated by large homogeneous regions in the normal mucosal structure, identified as lamina propria inflammation when correlated to expert H&E analysis. The evidence presented supports OCT being able to provide real-time identification of morphological features indicative of ACR.

Using current methods, it is essential that gross endoscopic clinical findings are confirmed against histopathologic biopsy, as endoscopic visual inspection alone provides insufficient sensitivity and specificity to diagnose ACR.57 The ileum is subject to the highest degree of acute rejection, as it maintains the highest concentration of lymphoid tissue in the gut, and therefore requires intense surveillance. For this reason, IT centers conduct two allograft biopsies per week for the first 6 weeks post-transplant and gradually decrease to once every 3 weeks, even in the absence of any symptoms of graft dysfunction.4 Since rejection may be focal, a minimum of three biopsies of the IT graft are often recommended, with sufficient depth to include observation of the full mucosal layer, muscularis mucosae, and superficial submucosa.56 Integrating OCT into the post-IT clinical workflow adds a much-needed layer of confidence toward identifying suspicious lesions, greatly reducing the number of biopsies required to diagnose and stage ACR accurately.

An important limitation of our system is the modest acquisition speed of the OCT engine (12 B-scans per second), which resulted in moderate motion artifacts in averaged B-scans. Two-handed operation of the OCT scanner was required to stabilize the distal end, which diminished motion artifacts. In preparation for in vivo work, future iterations of our probe will incorporate faster scanning speeds, along with advanced image registration techniques to address these concerns.

5.

Conclusion

We have presented the application of an endoscopic tool for assessing the status of transplanted intestinal tissue. The approach, based on a compact, portable OCT engine, has been adapted for endoscopic use using a rigid borescope and offers a form factor that will facilitate use in the operating suite. OCT is uniquely positioned as an informative imaging tool to assist in evaluating and grading IT rejection. OCT shows a promising path for in vivo analysis of IT-related pathologies by providing high-resolution cross-sectional images of the GI wall of the small intestine. We hope that this work further promotes OCT applications in the small bowel and improved understanding of the clinical progression of IT-related pathologies.

Disclosures

AW is the founder and president of Lumedica, Inc.

Acknowledgments

We gratefully thank Dan Cifelli of Foreal Spectrum for the loan of the borescope and Kengyeh Ken Chu for assistance in preparing this manuscript. Funding for this study was provided by the Coulter Translational Partnership, the National Science Foundation (NSF) (IIP-1827560), and the National Cancer Institute (R01-CA210544).

References

1. 

D. Sudan, “The current state of intestine transplantation: indications, techniques, outcomes and challenges,” Am. J. Transpl., 14 (9), 1976 –1984 (2014). https://doi.org/10.1111/ajt.12812 Google Scholar

2. 

S. Bharadwaj et al., “Current status of intestinal and multivisceral transplantation,” Gastroenterol. Rep., 5 (1), 20 –28 (2017). https://doi.org/10.1093/gastro/gow045 Google Scholar

3. 

J. Varkey, “Graft assessment for acute rejection after intestinal transplantation: current status and future perspective,” Scand. J. Gastroenterol., 56 (1), 13 –19 (2021). https://doi.org/10.1080/00365521.2020.1847318 Google Scholar

4. 

J. I. Moon, T. D. Schiano and K. R. Iyer, “Routine surveillance endoscopy and biopsy after isolated intestinal transplantation—revisiting the gold standard,” Clin. Transpl., 33 (10), e13684 (2019). https://doi.org/10.1111/ctr.13684 Google Scholar

5. 

M. Byrne et al., “Combined terminal ileoscopy and biopsy is superior to small bowel follow-through in detecting terminal ileal pathology,” Digest. Liver Disease, 36 (2), 147 –152 (2004). https://doi.org/10.1016/j.dld.2003.11.001 Google Scholar

6. 

B. Konkel et al., “Fully automated analysis of OCT imaging of human kidneys for prediction of post-transplant function,” Biomed. Opt. Express, 10 (4), 1794 –1821 (2019). https://doi.org/10.1364/BOE.10.001794 BOEICL 2156-7085 Google Scholar

7. 

J. G. Fujimoto et al., “Optical coherence tomography (OCT) in ophthalmology: introduction,” Opt. Express, 17 (5), 3978 –3979 (2009). https://doi.org/10.1364/OE.17.003978 Google Scholar

8. 

W. Drexler and J. G. Fujimoto, “Optical coherence tomography in ophthalmology,” J. Biomed. Opt., 12 (4), 041201 (2007). https://doi.org/10.1117/1.2773734 JBOPFO 1083-3668 Google Scholar

9. 

G. J. Tearney, I. -K. Jang and B. E. Bouma, “Optical coherence tomography for imaging the vulnerable plaque,” J. Biomed. Opt., 11 (2), 021002 (2006). https://doi.org/10.1117/1.2192697 Google Scholar

10. 

G. Yabushita et al., “Characterization of human atherosclerosis by optical coherence tomography,” Circulation, 106 (13), 1640 –1645 (2002). https://doi.org/10.1364/OL.21.000543 Google Scholar

11. 

H. Yoo et al., “Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo,” Nat. Med., 17 (12), 1680 –1684 (2011). https://doi.org/10.1038/nm.2555 Google Scholar

12. 

N. Hanna et al., “Two-dimensional and 3-dimensional optical coherence tomographic imaging of the airway, lung, and pleura,” J. Thorac. Cardiovasc. Surg. , 129 (3), 615 –622 (2005). Google Scholar

13. 

M. Tsuboi et al., “Optical coherence tomography in the diagnosis of bronchial lesions,” Lung Cancer, 49 (3), 387 –394 (2005). https://doi.org/10.1016/j.lungcan.2005.04.007 Google Scholar

14. 

S. A. Boppart et al., “Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer,” Breast Cancer Research and Treatment, 84 (2), 85 –97 (2004). https://doi.org/10.1023/B:BREA.0000018401.13609.54 Google Scholar

15. 

G. Jesser et al., “High resolution imaging of transitional cell carcinoma with optical coherence tomography: feasibility for the evaluation of bladder pathology,” The Br. J. Radiol., 72 (864), 1170 –1176 (1999). Google Scholar

16. 

L. P. Hariri et al., “Laparoscopic optical coherence tomography imaging of human ovarian cancer,” Gynecologic Oncol., 114 (2), 188 –194 (2009). https://doi.org/10.1016/j.ygyno.2009.05.014 Google Scholar

17. 

A. M. Sergeev et al., “In vivo endoscopic OCT imaging of precancer and cancer states of human mucosa,” Opt. Express, 1 (13), 432 –440 (1997). https://doi.org/10.1364/OE.1.000432 OPEXFF 1094-4087 Google Scholar

18. 

S. Song, J. Xu and R. K. Wang, “Long-range and wide field of view optical coherence tomography for in vivo 3D imaging of large volume object based on akinetic programmable swept source,” Biomed. Opt. Express, 7 (11), 4734 –4748 (2016). https://doi.org/10.1364/BOE.7.004734 BOEICL 2156-7085 Google Scholar

19. 

A. Baghaie, Z. Yu and R. M. D’Souza, “State-of-the-art in retinal optical coherence tomography image analysis,” Quant. Imaging Med. Surg., 5 (4), 603 (2015). https://doi.org/10.3978/j.issn.2223-4292.2015.07.02 Google Scholar

20. 

J. P. Ehlers et al., “Determination of feasibility and utility of microscope-integrated optical coherence tomography during ophthalmic surgery: the DISCOVER Study RESCAN results,” JAMA Ophthalmol., 133 (10), 1124 –1132 (2015). https://doi.org/10.1001/jamaophthalmol.2015.2376 Google Scholar

21. 

G. Song et al., “A review of low-cost and portable optical coherence tomography,” Prog. Biomed. Eng., 3 032002 (2021). https://doi.org/10.1088/2516-1091/abfeb7 PRBEEZ 0920-5438 Google Scholar

22. 

L. V. Wang and H.-I. Wu, Biomedical Optics: Principles and Imaging, John Wiley & Sons, Hoboken, New Jersey (2012). Google Scholar

23. 

O. M. Carrasco-Zevallos et al., “Review of intraoperative optical coherence tomography: technology and applications [Invited],” Biomed. Opt. Express, 8 (3), 1607 –1637 (2017). https://doi.org/10.1364/BOE.8.001607 BOEICL 2156-7085 Google Scholar

24. 

M. J. Gora et al., “Endoscopic optical coherence tomography: technologies and clinical applications [Invited],” Biomed. Opt. Express, 8 (5), 2405 –2444 (2017). https://doi.org/10.1364/BOE.8.002405 BOEICL 2156-7085 Google Scholar

25. 

G. Tearney et al., “Scanning single-mode fiber optic catheter–endoscope for optical coherence tomography,” Opt. Lett., 21 (7), 543 –545 (1996). https://doi.org/10.1364/OL.21.000543 OPLEDP 0146-9592 Google Scholar

26. 

P. H. Tran et al., “In vivo endoscopic optical coherence tomography by use of a rotational microelectromechanical system probe,” Opt. Lett., 29 (11), 1236 –1238 (2004). https://doi.org/10.1364/OL.29.001236 OPLEDP 0146-9592 Google Scholar

27. 

T.-H. Tsai et al., “Ultrahigh speed endoscopic optical coherence tomography using micromotor imaging catheter and VCSEL technology,” Biomed. Opt. Express, 4 (7), 1119 –1132 (2013). https://doi.org/10.1364/BOE.4.001119 BOEICL 2156-7085 Google Scholar

28. 

A. M. Rollins et al., “Real-time in vivo imaging of human gastrointestinal ultrastructure by use of endoscopic optical coherence tomography with a novel efficient interferometer design,” Opt. Lett., 24 (19), 1358 –1360 (1999). https://doi.org/10.1364/OL.24.001358 OPLEDP 0146-9592 Google Scholar

29. 

M. Strathman et al., “MEMS scanning micromirror for optical coherence tomography,” Biomed. Opt. Express, 6 (1), 211 –224 (2015). https://doi.org/10.1364/BOE.6.000211 BOEICL 2156-7085 Google Scholar

30. 

J. M. Poneros, “Diagnosis of Barrett’s esophagus using optical coherence tomography,” Gastrointest. Endoscopy Clin. N. Am., 14 (3), 573 –588 (2004). https://doi.org/10.1016/j.giec.2004.03.002 GECNED 1052-5157 Google Scholar

31. 

W. Hatta et al., “Optical coherence tomography for the staging of tumor infiltration in superficial esophageal squamous cell carcinoma,” Gastrointest. Endosc., 71 (6), 899 –906 (2010). https://doi.org/10.1016/j.gie.2009.11.052 Google Scholar

32. 

B. Shen et al., “In vivo colonoscopic optical coherence tomography for transmural inflammation in inflammatory bowel disease,” Clin. Gastroenterol. Hepatol., 2 (12), 1080 –1087 (2004). https://doi.org/10.1016/S1542-3565(04)00621-4 Google Scholar

33. 

D. C. Adler et al., “Three-dimensional endomicroscopy of the human colon using optical coherence tomography,” Opt. Express, 17 (2), 784 –796 (2009). https://doi.org/10.1364/OE.17.000784 OPEXFF 1094-4087 Google Scholar

34. 

P.-L. Hsiung et al., “Ultrahigh-resolution and 3-dimensional optical coherence tomography ex vivo imaging of the large and small intestines,” Gastrointest. Endosc., 62 (4), 561 –574 (2005). https://doi.org/10.1016/j.gie.2005.05.006 Google Scholar

35. 

Jr. M. V. Sivak et al., “High-resolution endoscopic imaging of the GI tract using optical coherence tomography,” Gastrointest. Endosc., 51 (4), 474 –479 (2000). https://doi.org/10.1016/S0016-5107(00)70450-0 Google Scholar

36. 

H.-C. Lee et al., “Mo1993 endoscopic optical coherence tomography microangiography identifies the altered microvasculature of the terminal ileum in Crohn’s disease,” Gastrointest. Endosc., 85 (5), AB511 –AB512 (2017). https://doi.org/10.1016/j.gie.2017.03.1180 Google Scholar

37. 

K. Kobayashi et al., “High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results,” Gastrointest. Endosc., 47 (6), 515 –523 (1998). https://doi.org/10.1016/S0016-5107(98)70254-8 Google Scholar

38. 

V. X. Yang et al., “Endoscopic Doppler optical coherence tomography in the human GI tract: initial experience,” Gastrointest. Endosc., 61 (7), 879 –890 (2005). https://doi.org/10.1016/S0016-5107(05)00323-8 Google Scholar

39. 

E. Masci et al., “Optical coherence tomography in the diagnosis of coeliac disease: a preliminary report,” Gut, 55 (4), 579 (2006). https://doi.org/10.1136/gut.2005.081364 GUTTAK 0017-5749 Google Scholar

40. 

E. T. Jelly, Z. A. Steelman and A. Wax, “Optical coherence tomography through a rigid borescope applied to quantification of articular cartilage thickness in a porcine knee model,” Opt. Lett., 44 (22), 5590 –5593 (2019). https://doi.org/10.1364/OL.44.005590 OPLEDP 0146-9592 Google Scholar

41. 

S. Kim et al., “Design and implementation of a low-cost, portable OCT system,” Biomed. Opt. Express, 9 (3), 1232 –1243 (2018). https://doi.org/10.1364/BOE.9.001232 BOEICL 2156-7085 Google Scholar

42. 

G. Song et al., “First clinical application of low-cost OCT,” Transl. Vision Sci. Technol., 8 (3), 61 (2019). https://doi.org/10.1167/tvst.8.3.61 Google Scholar

43. 

Y. Zhu et al., “Design and validation of an angle-resolved low-coherence interferometry fiber probe for in vivo clinical measurements of depth-resolved nuclear morphology,” J. Biomed. Opt., 16 (1), 011003 (2011). https://doi.org/10.1117/1.3520130 JBOPFO 1083-3668 Google Scholar

44. 

H. Gregerson et al., Essentials of Experimental Surgery: Gastroenterology, CRC Press(1996). Google Scholar

45. 

A. K. Sehgal et al., “Intestinal villi in rhesus monkeys,” Nature, 210 (5039), 972 –973 (1966). https://doi.org/10.1038/210972a0 Google Scholar

46. 

H. J. Freeman, A. B. R. Thomson, “The small intestine,” First Principles of Gastroenterology: The Basis of Disease and An Approach to Management A., 175 –177 Canadian Association of Gastroenterology Astra Pharmaceuticals, Toronto, Canada (2005). Google Scholar

47. 

D. M. de Bruin et al., “Assessment of apoptosis induced changes in scattering using optical coherence tomography,” J. Biophotonics, 9 (9), 913 –923 (2016). https://doi.org/10.1002/jbio.201500198 Google Scholar

48. 

T.-H. Tsai et al., “Comparison of tissue architectural changes between radiofrequency ablation and cryospray ablation in Barrett’s esophagus using endoscopic three-dimensional optical coherence tomography,” Gastroenterol. Res. Pract., 2012 684832 (2012). https://doi.org/10.1155/2012/684832 Google Scholar

49. 

P. Ruiz et al., “Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium,” Transplant. Proc., 36 (2), 335 –337 (2004). https://doi.org/10.1016/j.transproceed.2004.01.079 TRPPA8 0041-1345 Google Scholar

50. 

D. C. Chambers et al., “The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report—2017; focus theme: allograft ischemic time,” J. Heart Lung Transplant., 36 (10), 1047 –1059 (2017). https://doi.org/10.1016/j.healun.2017.07.016 Google Scholar

51. 

T. Asaoka et al., “Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies,” Transpl. Int., 24 (7), 697 –707 (2011). https://doi.org/10.1111/j.1432-2277.2011.01259.x Google Scholar

52. 

A. Lauro, I. R. Marino and C. S. Matsumoto, “Advances in allograft monitoring after intestinal transplantation,” Curr. Opin. Organ Transpl., 21 (2), 165 –170 (2016). https://doi.org/10.1097/MOT.0000000000000279 Google Scholar

53. 

D. F. Mercer, “Hot topics in postsmall bowel transplantation: noninvasive graft monitoring including stool calprotectin and plasma citrulline,” Curr. Opin. Organ Transpl., 16 (3), 316 –322 (2011). https://doi.org/10.1097/MOT.0b013e3283467115 Google Scholar

54. 

K. Abu-Elmagd et al., “Monitoring and treatment of intestinal allograft rejection in humans,” Transpl. Proc., 25 (1 Pt 2), 1202 –1203 (1993). TRPPA8 0041-1345 Google Scholar

55. 

R. G. Lee et al., “Pathology of human intestinal transplantation,” Gastroenterology, 110 (6), 1820 –1834 (1996). https://doi.org/10.1053/gast.1996.v110.pm8964408 GASTAB 0016-5085 Google Scholar

56. 

H. Remotti et al., “Small-bowel allograft biopsies in the management of small-intestinal and multivisceral transplant recipients: histopathologic review and clinical correlations,” Arch. Pathol. Lab. Med., 136 (7), 761 –771 (2012). https://doi.org/10.5858/arpa.2011-0596-RA APLMAS 0003-9985 Google Scholar

57. 

S. J. O’Keefe et al., “Endoscopic evaluation of small intestine transplant grafts,” Transplantation, 94 (7), 757 –762 (2012). https://doi.org/10.1097/TP.0b013e31825f4410 TRPLAU 0041-1337 Google Scholar

Biography

Evan T. Jelly is a PhD candidate working in the Department of Biomedical Engineering at Duke University. He received his BS degree in physics from The College of New Jersey and his MSc degree in biophotonics with distinction from Cardiff University. His present work is centered around the translation of low-cost optical coherence tomography (OCT) instrumentation. Outside of research, he is active in both scientific outreach and policy initiatives.

Jean Kwun is an assistant professor in the Department of Surgery at Duke University. He has received DVM and PhD degrees from the Seoul National University and the University of Wisconsin–Madison, respectively. His current research interests include humoral tolerance to organ transplants in animal models and humans, developing a clinically relevant animal model to study the mechanisms of antibody-mediated rejection (AMR), and establishing a conceptual basis that will translate into therapeutic intervention of AMR.

Robin Schmitz went to medical school in Heidelberg Germany and is now a senior general surgery resident at Duke University. He completed a research fellowship in the lab of Dr. Stuart Knechtle, during which he studied acute rejection in different nonhuman primate allotransplantation models, with special focus on acute antibody-mediated rejection in highly sensitized transplant recipients.

Alton B. Farris is director of the Laboratory of Nephropathology and Electron Microscopy at Emory University Hospital and a professor in the Emory Department of Pathology and Laboratory Medicine. He participates in kidney, gastrointestinal, and liver pathology clinical services, and his research interests include transplantation pathology and the application of artificial intelligence/machine learning to whole slide images. Recently, along these lines, he has helped co-lead the Banff Foundation for Allograft Pathology Digital Pathology Working Group.

Zachary A. Steelman received an MS degree in electrical and computer engineering and PhD in biomedical engineering from Duke University in 2020. He is currently serving as a National Research Council postdoctoral research associate in the Bioeffects Division of the United States Air Force Research Laboratory at Fort Sam Houston, San Antonio, Texas. He is a recipient of the National Science Foundation Graduate Research Fellowship.

Debra L. Sudan is a general surgeon in Durham, North Carolina, and is affiliated with Duke University Hospital. She received her medical degree from Wright State University Boonshoft School of Medicine. She specializes in hepatobiliary surgery and transplantation and is experienced in liver transplant surgery, intestinal failure, renal transplant surgery, general / gastrointestinal surgery, and hepatopancreatobiliary surgery.

Stuart J. Knechtle graduated from Weill Cornell Medical College of Cornell University in 1982, before completing a residency in general surgery at Duke University Hospital from 1986 to 1989. He then completed a fellowship in multi-organ transplantation at University of Wisconsin, Madison, from 1989 to 1991. His research aims are centered on the immunology of surgery and transplantation, including both cellular and antibody-mediated immune responses.

Adam Wax is a professor in the Department of Biomedical Engineering at Duke University. He founded Oncoscope, Inc., to commercialize early cancer detection technology developed in his laboratory in 2006 and founded Lumedica, Inc., to develop low cost OCT systems in 2014. He is a fellow of the Optical Society of America, SPIE, and AIMBE and is inventor on 19 US patents. He currently serves as editor-in-chief of the SPIE journal Optical Engineering.

CC BY: © The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI.
Evan T. Jelly, Jean Kwun, Robin Schmitz, Alton B. Farris, Zachary A. Steelman, Debra L. Sudan, Stuart J. Knechtle, and Adam P. Wax "Optical coherence tomography of small intestine allograft biopsies using a handheld surgical probe," Journal of Biomedical Optics 26(9), 096008 (24 September 2021). https://doi.org/10.1117/1.JBO.26.9.096008
Received: 5 April 2021; Accepted: 8 September 2021; Published: 24 September 2021
Lens.org Logo
CITATIONS
Cited by 3 scholarly publications.
Advertisement
Advertisement
KEYWORDS
Optical coherence tomography

Information technology

Biopsy

Intestine

Tissues

Endoscopy

Visualization

Back to Top